How many insider trades does FilingIQ track for PDEX?

FilingIQ tracks 322 Form 4 insider transactions for PDEX (PRO DEX INC), covering filings from May 26, 2015 onwards. 0 of those were filed in the last 90 days.

Are PDEX insiders net buyers or net sellers?

Across the full Form 4 history for PDEX, 25 transactions (8%) were open-market purchases and 170 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PDEX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PDEX in?

PRO DEX INC (PDEX) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $128.10M.

PDEX insider trading

NasdaqCM Healthcare

PRO DEX INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

322

Last 90 days

Buys / sells

8% / 53%

Market cap

$128.10M

About PRO DEX INC

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Company website: www.pro-dex.com

PDEX insider activity at a glance

FilingIQ has scored 322 insider transactions for PDEX since May 26, 2015. The most recent filing in our index is dated Jan 22, 2026.

Across the full history, 25 open-market purchases and 170 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PDEX insider trades is 54.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PDEX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PDEX?: FilingIQ tracks 322 Form 4 insider transactions for PDEX (PRO DEX INC), covering filings from May 26, 2015 onwards. 0 of those were filed in the last 90 days.
Are PDEX insiders net buyers or net sellers?: Across the full Form 4 history for PDEX, 25 transactions (8%) were open-market purchases and 170 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PDEX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PDEX in?: PRO DEX INC (PDEX) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $128.10M.

Methodology & sources

Every PDEX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.